Tier Biotech Investor to Advance Preclinical Programs and Extend Cash Runway Progressed Pipeline with New Preclinical Data ...
SAN DIEGO, Aug. 19, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (Nasdaq: IBIO), an AI-driven innovator of precision antibody therapies, today announced the pricing of an underwritten public offering (the ...
The market expects Bandwidth (BAND) to deliver a year-over-year decline in earnings on lower revenues when it reports results ...
SAN DIEGO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (Nasdaq: IBIO), an AI-driven innovator of precision antibody therapies, today announced it has commenced an underwritten public offering (the ...
News of the omicron variant of Covid-19 has sent vaccine makers into a frenzy, as companies race to make further adaptations. Many of the leading vaccine makers have already begun testing and ...
NEW YORK, June 26, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) (“iBio” or the “Company”), a biologics innovator and contract manufacturing organization, today announced that it will be ...
Even though biotechnology company iBio (IBIO) reported some positive developments related to its COVID-19 vaccine candidates this month, it is way behind competitors that are already distributing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results